Pleiotropic effects of statins in atrial fibrillation patients: the evidence. - Wikidata - awgldk - TriplyDB

Pleiotropic effects of statins in atrial fibrillation patients: the evidence.

Pleiotropic effects of statins in atrial fibrillation patients: the evidence.

http://www.wikidata.org/entity/Q37248230

about

Applied Healthspan engineering.Antiarrhythmic effects of simvastatin in canine pulmonary vein sleeve preparations Inflammatory cytokines and atrial fibrillation: current and prospective views Atrial Fibrillation at an Internal Medicine Ward: Clinical and Prognostic Implications.Cholesterol and cardiac arrhythmias.Cytokine Effects on Mechano-Induced Electrical Activity in Atrial Myocardium.Statin therapy exacerbates alcohol-induced constriction of cerebral arteries via modulation of ethanol-induced BK channel inhibition in vascular smooth muscle.

P2860

Q34157133-14F04167-0C21-4E5D-B30E-617BA14C9EA2 Q34682939-3AA6DE9C-A16C-4AB7-9D8B-298F34843857 Q35557385-CA3AD97B-3205-43A9-8506-8F07528A691F Q37495827-65A9F88E-AAE9-496B-9424-10FB0C4D2AF2 Q37770110-F5617BC9-E781-41BD-8CB9-7B14AD0C9114 Q38951853-AF80C507-887C-438F-9D5B-28C01EBB676C Q47865448-BAAF8E53-05E1-4DEA-985C-8098561B6E95

P2860

Pleiotropic effects of statins in atrial fibrillation patients: the evidence.

http://www.wikidata.org/entity/Q37248230

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 29 June 2009

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Pleiotropic effects of statins in atrial fibrillation patients: the evidence.

@en

Pleiotropic effects of statins in atrial fibrillation patients: the evidence.

@nl

type

label

Pleiotropic effects of statins in atrial fibrillation patients: the evidence.

@en

Pleiotropic effects of statins in atrial fibrillation patients: the evidence.

@nl

prefLabel

Pleiotropic effects of statins in atrial fibrillation patients: the evidence.

@en

Pleiotropic effects of statins in atrial fibrillation patients: the evidence.

@nl

P1433

Q37248230-90EB0276-F188-4563-82D9-CC6645F6CEC0

P1476

Q37248230-83456080-9B33-4038-B628-C57D5FB55E3C

P2093

Q37248230-13877FDE-AEA7-4695-9A7B-92B45338797B

Q37248230-C1BCF52B-138D-43C4-ABBA-64D17C6DA050

Q37248230-F10D6A16-CA7C-4B59-BA4B-71F3424FA75F

Q37248230-FF6C4D6A-1BF6-4A9E-8978-7D2198559719

P2860

Q37248230-022C6460-FD54-4FED-AABD-D43DBE6E8C26

Q37248230-03263083-2464-4B65-BEDE-60DF96B5FE93

Q37248230-09844E94-3AFD-4470-9E4C-FEB8939D77CE

Q37248230-11C8BAD0-C639-4AF9-A72A-8E1BC27FF953

Q37248230-134D787A-1931-4A77-8975-573443D49B23

Q37248230-18D3AEC7-0AB2-4275-909F-627422577B3E

Q37248230-1D794EDB-56EC-4544-9B3C-7F687E9FDD3E

Q37248230-1FE197DA-9A8D-4726-8ED9-AE0976459726

Q37248230-21802941-3F50-4FDD-A486-10BAC3F379E3

Q37248230-22144549-9631-428E-8ACF-17C470264439

P304

Q37248230-5072EA24-C0B6-47CF-8AC7-DE0F4F9ED77A

P31

Q37248230-A051376D-2912-4D7B-8774-B315624DEF0B

Q37248230-ABBAE30B-C53E-4D94-9D1D-430F52FD7B5E

P356

Q37248230-7A8B0837-DE2F-480C-9E9C-76BFFA49FDB4

P407

Q37248230-3A844462-53B4-43B2-A63F-7558D837F6D6

P433

Q37248230-E5B224B3-BA88-4738-A5D8-514362277B6A

P478

Q37248230-726C65D1-3D72-4AF0-83BA-71018E6B65F4

P577

Q37248230-408A0B48-B268-49ED-A4DA-30C8B39B31A7

P698

Q37248230-7FC7E482-7D47-46F3-AE3F-53EB58B6C65D

P921

Q37248230-112CFE01-BA9C-428A-9491-4ED84B994293

Q37248230-AB683F92-AEF9-45C6-8D6E-21B7DC05515C

P932

Q37248230-F600CA83-C5A2-4FB9-9FF8-3F622831170C

P356

P1433

Vascular Health and Risk Management

P1476

Pleiotropic effects of statins in atrial fibrillation patients: the evidence.

@en

P2093

Hadi Ar Hadi

http://www.w3.org/2001/XMLSchema#string

Jassim Al Suwaidi

http://www.w3.org/2001/XMLSchema#string

Samer Ellahham

http://www.w3.org/2001/XMLSchema#string

Wael Al Mahmeed

http://www.w3.org/2001/XMLSchema#string

P2860

Effect of statin therapy on C-reactive protein levels: the pravastatin inflammation/CRP evaluation (PRINCE): a randomized trial and cohort study

C-reactive protein and other inflammatory risk markers in acute coronary syndromes

Effect of statin dose on incidence of atrial fibrillation: data from the Pravastatin or Atorvastatin Evaluation and Infection Therapy-Thrombolysis in Myocardial Infarction 22 (PROVE IT-TIMI 22) and Aggrastat to Zocor (A to Z) trials.

Interleukin-6 and atrial fibrillation in patients with coronary artery disease: data from the Heart and Soul Study.

Cellular mechanisms of depressed atrial contractility in patients with chronic atrial fibrillation.

Pathophysiology and prevention of atrial fibrillation.

Anti-inflammatory and immunomodulatory effects of statins.

Inflammation as a risk factor for atrial fibrillation.

The paradigm of IL-6: from basic science to medicine

Histological substrate of atrial biopsies in patients with lone atrial fibrillation.

P304

533-551

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.2147/VHRM.S4841

http://www.w3.org/2001/XMLSchema#string

P407

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

5

http://www.w3.org/2001/XMLSchema#string

P577

2009-06-29T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

19590588

http://www.w3.org/2001/XMLSchema#string

P921

mechanism of action

atrial fibrillation

P932

2704895

http://www.w3.org/2001/XMLSchema#string